Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2008-07-22
2008-07-22
Gabel, Gailene R. (Department: 1641)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S001110, C424S001130, C424S001170, C424S001330, C424S001370, C424S001570, C424S001850, C424S009200, C424S001210, C424S009400, C424S009450, C436S035000, C436S057000, C436S058000, C436S063000, C436S064000, C436S125000
Reexamination Certificate
active
10999313
ABSTRACT:
New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.
REFERENCES:
patent: 4490543 (1984-12-01), Bergquist et al.
patent: 4599227 (1986-07-01), Dees et al.
patent: 4647578 (1987-03-01), Crounse et al.
patent: 4846789 (1989-07-01), Heitz et al.
patent: 4957481 (1990-09-01), Gatenby
patent: 4973848 (1990-11-01), Kolobanov et al.
patent: 5053006 (1991-10-01), Watson
patent: 5128139 (1992-07-01), Brown et al.
patent: 5149801 (1992-09-01), Kahl et al.
patent: 5177073 (1993-01-01), Gulliya et al.
patent: 5284831 (1994-02-01), Kahl et al.
patent: 5573773 (1996-11-01), Kis et al.
patent: 5576013 (1996-11-01), Williams et al.
patent: 5591422 (1997-01-01), Hemmi et al.
patent: 5654423 (1997-08-01), Kahl et al.
patent: 5827186 (1998-10-01), Chen et al.
patent: 5829448 (1998-11-01), Fisher et al.
patent: 5832931 (1998-11-01), Wachter et al.
patent: 5998597 (1999-12-01), Fisher et al.
patent: 6036941 (2000-03-01), Bottiroli et al.
patent: 6042603 (2000-03-01), Fisher et al.
patent: 6331286 (2001-12-01), Dees et al.
patent: 2007/0010575 (2007-01-01), Dees et al.
patent: 0 064 012 (1982-11-01), None
patent: 0 175 617 (1985-09-01), None
patent: 06-128128 (1994-05-01), None
patent: WO 96/07431 (1996-03-01), None
patent: WO 97/03697 (1997-02-01), None
patent: WO 97/26920 (1997-07-01), None
patent: WO 97/39064 (1997-10-01), None
patent: WO 00/25665 (2000-05-01), None
patent: WO 00/25819 (2000-05-01), None
patent: WO 00/25829 (2000-05-01), None
patent: WO 00/37927 (2000-06-01), None
Neckers D., Rose Bengal, Journal of Photochemistry and Photobiology, A: Chemistry 47: 1-29 (1989).
Serafini et al., Iodine 123-Rose Bengal: An Improved Hepatobiliary Imaging Agent, Journal of Nuclear Medicine: 16 (7): 629-632 (1975).
Xanthenes: Fluorone Derivatives, The Journal of Organic Chemistry 57(1992) Jul. 31, No. 16, Washington, DC pp. 4418-4421.
(Svensk Farmaceutisk Tidskrift (1973) 77 (13): 641-647 (Abstract).
Z. Diwu and J.W. Lown, “Phototherapeutic potential of alternative photosensitizers to porphyrins,” Pharmac. Ther., 63 (1994) 1-35.
J.R. Heitz and W.W. Wilson, “Photodegradation of halogenated xanthene dyes,” Mississippi Agriculture and Forestry Experiment Station (MAFES), Publication 8532, 35-48.
K. Kalka, H. Merk, and H. Mukhtar, “Photodynamic therapy in dermatology,” J.Am. Acad. Derm., 42 (2000) 389-413.
H. Von Tappeiner and A. Jesionek, “Therapeutische versuche mit fluoreszierenden Stoffen (Therapeutic experiments with flourescent substances)”, Munch. Med. Wochenschr., 47 (1903) 2042-2044.
U.S. Appl. No. 09/096,832 (pending) to Wachter, et al. filed Jun. 12, 1998, including specification, claims abstract drawings and PTO filing receipt.
Search Report re: PCT/US01/08924. Dated Jun. 22, 2001.
Young, S. et al, “Gadolinium(III) Texaphyrin: A Tumor Selective Radiation Sensitizer that is Detectable by MRI,” Proc. Natl. Acad. Sci., vol. 93, pp. 6610-6615, Jun. 1996.
Bernhard, E.J. et al, “Re-Evaluating Gadolinium(III) Texaphyrin as a Radiosensitizing Agent,” Cancer Research, vol. 60, pp. 86-91, Jan. 1, 2000.
Fisher et al., “Clinical and Preclinical Photodynamic Therapy”,Lasers In Surgery and Medicine, vol. 17, p. 2-31, 1995.
Springer-Verlang Berlin Heidelberg 1996; Library of Congress Cataloging-in-Publication Data applied for, pp. 46-85. Laser-Tissue Interactions Fundamental and Applications by Markolf H. Niemz.
Journal of PHotochemistry and Photobiology, A: Chemistry, 47 (1989) pp. 1-29. Rose Bengal by D. C. Neckers.
Supplementary Partial European Search Report dated Mar. 31, 2004.
U.S. Appl. No. 11/124,654, filed May 9, 2005.
U.S. Appl. No. 09/635,276, filed Aug. 9, 2000.
U.S. Appl. No. 09/799,785, filed Mar. 6, 2001.
U.S. Appl. No. 09/817,448, filed Mar. 26, 2001.
U.S. Appl. No. 10/331,854, filed Dec. 30, 2002.
U.S. Appl. No. 09/900,355, filed Feb. 6, 2001.
Dees H. Craig
Fisher Walter G.
Scott Timothy C.
Smolik John
Wachter Eric A.
Cook Alex McFarron Manzo Cummings & Mehler, Ltd.
Gabel Gailene R.
Provectus Pharmatech, Inc.
LandOfFree
Intracorporeal medicaments for photodynamic treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracorporeal medicaments for photodynamic treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracorporeal medicaments for photodynamic treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3913969